IP Library Granted Patent US 8,778,378
Granted Patent B2
US 8,778,378 · App. 12/643,002 · Granted Jul 15, 2014

Bioactive antibacterial bone graft materials

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,778,378
App. No.
12/643,002
Granted
Jul 15, 2014
Kind
B2
Abstract

The present invention generally relates to bioactive antibacterial materials and composites that enhance bone growth while preventing surgical site infection. The present invention also relates to bioactive antibacterial materials and composites that include a bimodal bioactive glass particle size distribution. The bioactive antibacterial composite finds utility in a variety of clinical applications including spine and orthopaedic procedures.

Claims (20)

1. A bioactive antibacterial composite comprising a biocompatible polymer, a porous calcium phosphate and a bioactive glass, wherein the bioactive glass consists of:

(a) particles having a particle size of less than about 53 microns (μm) and

(b) particles having a particle size range from about 90 microns (μm) to about 150 microns (μm),

wherein the biocompatible polymer is present in an amount from about 10% to about 20% by weight of the composite, the calcium phosphate is present in an amount from about 50% to about 75% by weight of the composite and the bioactive glass is present in an amount from about 10% to about 35% by weight of the composite, and

wherein the bioactive antibacterial composite has antibacterial efficacy of greater than about 3.7 log reduction at 1 day when tested based on USP <51> standard at a bioactive glass concentration of between about 50 to about 200 mg/mL.

2. The bioactive antibacterial composite of claim 1 , wherein the biocompatible polymer is collagen.

3. The bioactive antibacterial composite of claim 1 , wherein the calcium phosphate is beta-tricalcium phosphate.

4. The bioactive composite of claim 1 , wherein the bioactive glass is 45S5 or Combeite.

5. The bioactive antibacterial composite of claim 1 , wherein the composite has a total porosity of at least 30% and interconnected macro-, meso- and microporosity.

6. The bioactive antibacterial composite of claim 1 , wherein the biocompatible polymer is collagen and the calcium phosphate is beta-tricalcium phosphate.

7. A bioactive antibacterial composite comprising a biocompatible polymer, a porous calcium phosphate and a bioactive glass, wherein about 50% by weight of the bioactive glass comprises particles with a particle size of less than about 53 μm and about 50% by weight of the bioactive glass comprises particles having a particle size range from about 90 μm to about 150 μm, wherein the bioactive antibacterial composite has antibacterial efficacy of greater than about 3.7 log reduction at 1 day when tested based on USP <51> standard at a bioactive glass concentration of between about 50 to about 200 mg/mL.

8. A method for repairing a defect in bone and preventing surgical site infection comprising the step of administering the bioactive antibacterial composite of claim 1 or 7 to the bone.

9. The method of claim 8 , wherein the defect is a defect in the spine.

10. The method of claim 8 , wherein the defect is a defect in the vertebral body.

11. A method for repairing a damaged bone or tooth comprising placing the bioactive antibacterial composite of claim 1 or 7 in the bone or jaw.

12. The bioactive antibacterial composite of claim 7 , wherein the biocompatible polymer is collagen.

13. The bioactive antibacterial composite of claim 7 , wherein the calcium phosphate is beta-tricalcium phosphate.

14. The bioactive composite of claim 12 , wherein the bioactive glass is 45S5 or Combeite.

15. The bioactive antibacterial composite of claim 7 , wherein the composite has a total porosity of at least 30% and interconnected macro-, meso- and microporosity.

16. The bioactive antibacterial composite of claim 7 , wherein the biocompatible polymer is collagen and the calcium phosphate is beta-tricalcium phosphate.

Assignments (4)
CHANGE OF ADDRESS Recorded Dec 18, 2024
From: STRYKER CORPORATION
To: STRYKER CORPORATION
Reel/Frame 069737/0184 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 1, 2023
From: ORTHOVITA, INC.
To: STRYKER CORPORATION
Reel/Frame 065735/0360 →
RELEASE OF SECURITY INTEREST Recorded Jan 22, 2015
From: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
To: BROCADE COMMUNICATIONS SYSTEMS, INC.; FOUNDRY NETWORKS, LLC
Reel/Frame 034804/0793 →
SECURITY AGREEMENT Recorded Jan 20, 2010
From: BROCADE COMMUNICATIONS SYSTEMS, INC.; FOUNDRY NETWORKS, LLC; INRANGE TECHNOLOGIES CORPORATION; MCDATA CORPORATION; MCDATA SERVICES CORPORATION
To: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 023814/0587 →